NERM
ABT icon

New England Research & Management’s Abbott ABT Stock Holding History

New England Research & Management’s Portfolio ABT Stock Details ABT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.92M Sell
21,174
-700
-3% -$63.9K 0.75% 42
2026
Q1 		$2.25M Sell
21,874
-1,700
-7% -$192K 0.95% 33
2025
Q4 		$2.95M Buy
23,574
+13,240
+128% +$1.69M 1.29% 20
2025
Q3 		$1.38M Hold
10,334
– – 0.64% 53
2025
Q2 		$1.41M Sell
10,334
-8,550
-45% -$1.13M 0.67% 48
2025
Q1 		$2.5M Sell
18,884
-1,695
-8% -$216K 1.27% 21
2024
Q4 		$2.33M Sell
20,579
-5,531
-21% -$639K 1.18% 22
2024
Q3 		$2.98M Buy
26,110
+8,550
+49% +$938K 1.4% 15
2024
Q2 		$1.82M Sell
17,560
-700
-4% -$74.2K 0.88% 37
2024
Q1 		$2.08M Sell
18,260
-314
-2% -$36K 1.02% 30
2023
Q4 		$2.04M Sell
18,574
-200
-1% -$20K 1.08% 26
2023
Q3 		$1.82M Sell
18,774
-400
-2% -$42K 1.04% 27
2023
Q2 		$2.09M Sell
19,174
-190
-1% -$20.3K 1.21% 24
2023
Q1 		$1.96M Sell
19,364
-280
-1% -$29.6K 1.15% 25
2022
Q4 		$2.16M Sell
19,644
-1,900
-9% -$197K 1.24% 21
2022
Q3 		$2.08M Sell
21,544
-12,324
-36% -$1.31M 1.31% 21
2022
Q2 		$3.68M Buy
33,868
+2,905
+9% +$330K 2.14% 6
2022
Q1 		$3.67M Buy
30,963
+5,360
+21% +$664K 1.9% 9
2021
Q4 		$3.6M Sell
25,603
-50
-0.2% -$6.4K 1.74% 11
2021
Q3 		$3.03M Sell
25,653
-100
-0.4% -$12.3K 1.59% 12
2021
Q2 		$2.99M Hold
25,753
– – 1.54% 13
2021
Q1 		$3.09M Sell
25,753
-100
-0.4% -$11.8K 1.69% 10
2020
Q4 		$2.83M Sell
25,853
-625
-2% -$67.9K 1.75% 8
2020
Q3 		$2.88M Sell
26,478
-75
-0.3% -$7.61K 2.09% 7
2020
Q2 		$2.43M Hold
26,553
– – 1.74% 10
2020
Q1 		$2.1M Buy
26,553
+1,400
+6% +$117K 1.79% 13
2019
Q4 		$2.19M Sell
25,153
-25
-0.1% -$2.09K 1.46% 13
2019
Q3 		$2.11M Sell
25,178
-200
-0.8% -$17K 1.53% 11
2019
Q2 		$2.13M Sell
25,378
-400
-2% -$31.5K 1.45% 9
2019
Q1 		$2.06M Sell
25,778
-2,050
-7% -$153K 1.39% 11
2018
Q4 		$2.01M Sell
27,828
-4,398
-14% -$309K 1.58% 11
2018
Q3 		$2.36M Buy
32,226
+10,449
+48% +$686K 1.54% 9
2018
Q2 		$1.33M Sell
21,777
-550
-2% -$33.3K 0.88% 37
2018
Q1 		$1.34M Sell
22,327
-500
-2% -$30.1K 0.9% 41
2017
Q4 		$1.3M Sell
22,827
-675
-3% -$37.4K 0.93% 39
2017
Q3 		$1.25M Sell
23,502
-1,075
-4% -$53.9K 0.92% 42
2017
Q2 		$1.2M Sell
24,577
-300
-1% -$13.6K 0.88% 36
2017
Q1 		$1.1M Sell
24,877
-4,350
-15% -$188K 0.85% 37
2016
Q4 		$1.12M Buy
29,227
+5,350
+22% +$212K 0.88% 29
2016
Q3 		$1.01M Sell
23,877
-7,150
-23% -$306K 0.85% 37
2016
Q2 		$1.22M Buy
31,027
+15,900
+105% +$633K 1.05% 27
2016
Q1 		$633K Sell
15,127
-800
-5% -$31.7K 0.54% 64
2015
Q4 		$715K Sell
15,927
-500
-3% -$22.1K 0.62% 59
2015
Q3 		$661K Sell
16,427
-400
-2% -$18.9K 0.63% 56
2015
Q2 		$826K Sell
16,827
-600
-3% -$28.8K 0.68% 55
2015
Q1 		$807K Sell
17,427
-1,331
-7% -$61.1K 0.69% 52
2014
Q4 		$844K Sell
18,758
-50
-0.3% -$2.18K 0.72% 46
2014
Q3 		$782K Hold
18,808
– – 0.68% 57
2014
Q2 		$769K Sell
18,808
-500
-3% -$19.6K 0.69% 61
2014
Q1 		$744K Buy
19,308
+3,750
+24% +$145K 0.68% 61
2013
Q4 		$596K Buy
+15,558
New +$573K 0.58% 69

Other funds holding ABT

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New England Research & Management's ABT Position: Q2 2026 in Review

New England Research & Management reduced its Abbott (ABT) stake by 3.2% in Q2 2026, selling an estimated $63.9K and leaving 21,174 shares worth $1.92M. The position accounts for 0.75% of the portfolio, ranked #42.

New England Research & Management first reported a position in ABT in Q4 2013 and has held it in 51 quarters since. The position peaked at $3.68M in Q2 2022. 1,385 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • New England Research & Management held 21,174 shares of Abbott worth $1.92M as of Q2 2026.
  • New England Research & Management sold 700 Abbott shares in Q2 2026, an estimated $63.9K.
  • Abbott made up 0.75% of New England Research & Management's portfolio in Q2 2026, its #42 holding.
  • New England Research & Management first reported a position in Abbott in Q4 2013 and has held it in 51 quarters since.
  • New England Research & Management's Abbott position peaked at $3.68M in Q2 2022.
  • 1,385 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on New England Research & Management's 13F filing for Q2 2026, filed 9 Jul 2026.